⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
Lost Money on Regeneron Pharmaceuticals, Inc. (REGN)? Join Class Action Before September 14, 2026 - Contact Levi & Korsinsky
accessnewswire.com
REGN
REGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regeneron Pharmaceuticals, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
REGN
Lost Money on Regeneron Pharmaceuticals, Inc. (REGN)? Contact Levi & Korsinsky Before September 14, 2026 to Join Class Action
accessnewswire.com
REGN
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Regeneron Pharmaceuticals, Inc. (REGN) Investors of September 14, 2026 Deadline
accessnewswire.com
REGN
Investors Urged to Contact Levi & Korsinsky for Information Before September 14, 2026 - Regeneron Pharmaceuticals, Inc. (REGN)
accessnewswire.com
REGN
Levi & Korsinsky Notifies Regeneron Pharmaceuticals, Inc. (REGN) Investors - Lead Plaintiff Deadline on September 14, 2026
accessnewswire.com
REGN
Class Action Lawsuit Filed Against Regeneron Pharmaceuticals, Inc. (REGN) - Recover Losses - Contact Levi & Korsinsky Before September 14, 2026
accessnewswire.com
REGN
Securities Lawsuit Alert: Regeneron Pharmaceuticals, Inc. (REGN) – Contact Levi & Korsinsky Before September 14, 2026
accessnewswire.com
REGN
Telix Q2 Revenue US$247M, Strong Momentum and Pipeline Progress
globenewswire.com
TLX
REGN
Lost Money on Regeneron Pharmaceuticals, Inc. (REGN)? Contact Levi & Korsinsky to Join Class Action Before September 14, 2026
accessnewswire.com
REGN